Zolsketil pegylated liposomal Eiropas Savienība - latviešu - EMA (European Medicines Agency)

zolsketil pegylated liposomal

accord healthcare s.l.u. - doxorubicin hydrochloride, liposomal - ovarian neoplasms; sarcoma, kaposi; multiple myeloma - doksorubicīns - zolsketil pegylated liposomal is a medicine used to treat the following types of cancer in adults:• breast cancer that has spread to other parts of the body in patients at risk of heart problems. zolsketil pegylated liposomal is used on its own for this disease;• advanced ovarian cancer in women whose previous treatment including a platinum-based cancer medicine has stopped working;• multiple myeloma (a cancer of the white blood cells in the bone marrow), in patients with progressive disease who have received at least one other treatment in the past and have already had, or are unsuitable for, a bone marrow transplantation. zolsketil pegylated liposomal is used in combination with bortezomib (another cancer medicine);• kaposi’s sarcoma in patients with aids who have a very damaged immune system. kaposi’s sarcoma is a cancer that causes abnormal tissue to grow under the skin, on moist body surfaces or on internal organs. zolsketil pegylated liposomal contains the active substance doxorubicin and is a ‘hybrid medicine’. this means that it is similar to a ‘reference medicine’ containing the same active substance called adriamycin. however, in zolsketil pegylated liposomal the active substance is enclosed in tiny fatty spheres called liposomes, whereas this is not the case for adriamycin.

Telmisartan Actavis Eiropas Savienība - latviešu - EMA (European Medicines Agency)

telmisartan actavis

actavis group ptc ehf - telmisartāns - hipertensija - agents, kas iedarbojas uz renīna-angiotenzīna sistēmu - hypertensiontreatment būtiski hipertensija pieaugušajiem. sirds un asinsvadu preventionreduction par sirds un asinsvadu slimību pacientiem ar acīmredzamām atherothrombotic sirds un asinsvadu slimības (anamnēzē ir koronārā sirds slimība, insults vai perifēro artēriju slimību); vai 2. tipa cukura diabētu ar dokumentētu mērķa orgānu bojājumu.

Dabigatran Etexilate Accord Eiropas Savienība - latviešu - EMA (European Medicines Agency)

dabigatran etexilate accord

accord healthcare s.l.u. - dabigatrāna eteksilāta mesilāts - venous thromboembolism; arthroplasty, replacement - antitrombotiskie līdzekļi - prevention of venous thromboembolic events.

Tanakan 40 mg apvalkotās tabletes Latvija - latviešu - Zāļu valsts aģentūra

tanakan 40 mg apvalkotās tabletes

ipsen consumer healthcare, france - divdaivu gika ekstrakts, standartizēts - apvalkotā tablete - 40 mg

Triveram 10 mg/5 mg/5 mg apvalkotās tabletes Latvija - latviešu - Zāļu valsts aģentūra

triveram 10 mg/5 mg/5 mg apvalkotās tabletes

les laboratoires servier, france - atorvastatinum, perindoprili argininum, amlodipinum - apvalkotā tablete - 10 mg/5 mg/5 mg

Triveram 20 mg/10 mg/5 mg apvalkotās tabletes Latvija - latviešu - Zāļu valsts aģentūra

triveram 20 mg/10 mg/5 mg apvalkotās tabletes

les laboratoires servier, france - atorvastatinum, perindoprili argininum, amlodipinum - apvalkotā tablete - 20 mg/10 mg/5 mg

Triveram 20 mg/10 mg/10 mg apvalkotās tabletes Latvija - latviešu - Zāļu valsts aģentūra

triveram 20 mg/10 mg/10 mg apvalkotās tabletes

les laboratoires servier, france - atorvastatinum, perindoprili argininum, amlodipinum - apvalkotā tablete - 20 mg/10 mg/10 mg

Triveram 20 mg/5 mg/5 mg apvalkotās tabletes Latvija - latviešu - Zāļu valsts aģentūra

triveram 20 mg/5 mg/5 mg apvalkotās tabletes

les laboratoires servier, france - atorvastatinum, perindoprili argininum, amlodipinum - apvalkotā tablete - 20 mg/5 mg/5 mg

Triveram 40 mg/10 mg/10 mg apvalkotās tabletes Latvija - latviešu - Zāļu valsts aģentūra

triveram 40 mg/10 mg/10 mg apvalkotās tabletes

les laboratoires servier, france - atorvastatinum, perindoprili argininum, amlodipinum - apvalkotā tablete - 40 mg/10 mg/10 mg

Buscopan 10 mg apvalkotās tabletes Latvija - latviešu - Zāļu valsts aģentūra

buscopan 10 mg apvalkotās tabletes

ipsen consumer healthcare, france - hioscīna butilbromīds - apvalkotā tablete - 10 mg